PainChek Limited (ASX:PCK)

Market Cap	30.31M -58.9%
Revenue (ttm)	3.44M +13.6%
Net Income	-9.22M
EPS	-0.05
Shares Out	209.01M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	154,877
Open	0.1500
Previous Close	0.1500
Day's Range	0.1400 - 0.1550
52-Week Range	0.1250 - 1.0500
Beta	0.50
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 31, 2026

About PainChek

PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, a clinically validated and regulatory cleared pain assessment technology that uses cameras in smartphones for a facial scan that is analyzed using facial recognition software to indicate the presence of pain. It serves patients suffering with dementia and pre-verbal infants; and the aged care, disability, home care, hospital, and infant s...

• Industry: Health Information Services
• Sector: Healthcare
• CEO: Philip Daffas
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: PCK

Financial Performance

In fiscal year 2025, PainChek's revenue was 3.36 million, an increase of 25.84% compared to the previous year's 2.67 million. Losses were -7.67 million, -7.65% less than in 2024.